EUVIMEDEUVIMED entdecken
Crossref

Multimodal chromatography solutions for the removal of light chain impurity from a fab therapeutic

Dongyoun Jang iD, Nathan Nicholes iD, Steven M Cramer iD

Biotechnology Progress · 17.08.2026

DOI: 10.1002/btpr.88551 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology Progress, online erschienen am 17.08.2026. Verfasst von Dongyoun Jang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biological Engineering and Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy,…. Die Arbeit nennt 36 Literaturangaben. Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The production of Fab therapeutics is frequently challenged by an imbalanced expression of light chains (LC) and heavy chains (HC), often resulting in LC‐associated impurities. In this work, we evaluated multimodal chromatography as an alternative to affinity chromatography for the removal of an LC impurity. A panel of multimodal CEX and multimodal AEX resins was screened using linear salt and pH gradients to assess Fab monomer and LC impurity selectivities. Product and impurity characterization was carried out using analytical size‐exclusion chromatography. Screening data provided insight into the relative contributions of hydrophobic and electrostatic interactions in the Fab and LC impurity selectivities across different multimodal ligands. A previously developed separability scoring metric (Fractional Peak Overlap) was employed to identify Eshmuno HCX and CMM HyperCel as the top resin candidates from the screening data. Finally, bench‐scale refinement was carried out to develop an Eshmuno HCX bind‐elute step with a 95%–100% recovery and 95%–98% purity of Fab monomer and a CMM HyperCel bind‐elute step with a 98%–99% recovery and 98% purity of Fab monomer. This work demonstrates the efficacy of this PD workflow and the utility of multimodal chromatography for removal of LC impurities from Fabs.

Schlagwörter

Stichwörter der Autor:innen

fab purificationmultimodal chromatographyseparability, downstream processingLC impurity

Autor:innen und Institutionen

  • Department of Chemical and Biological Engineering and Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, New York, USA.
  • Technical Development, Biogen Inc., Durham, North Carolina, USA.

ORCID-Profile: Dongyoun Jang, Nathan Nicholes, Steven M Cramer

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Jang, D., Nicholes, N., & Cramer, S. M. (2026). Multimodal chromatography solutions for the removal of light chain impurity from a fab therapeutic. Biotechnology Progress. https://doi.org/10.1002/btpr.88551

Vancouver

Jang D, Nicholes N, Cramer SM. Multimodal chromatography solutions for the removal of light chain impurity from a fab therapeutic. Biotechnology Progress. 2026. doi:10.1002/btpr.88551

BibTeX
@article{Jang2026,
  author = {Jang, Dongyoun and Nicholes, Nathan and Cramer, Steven M},
  title = {Multimodal chromatography solutions for the removal of light chain impurity from a fab therapeutic},
  journal = {Biotechnology Progress},
  year = {2026},
  doi = {10.1002/btpr.88551}
}
Kostenlos starten →